PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | +35.2% | 74,084 | +69.0% | 0.01% | +14.3% |
| Q2 2023 | $71 | -11.2% | 43,836 | +103.8% | 0.01% | -30.0% |
| Q4 2022 | $80 | -100.0% | 21,514 | -84.3% | 0.01% | -91.5% |
| Q3 2021 | $1,147,000 | +177.7% | 137,003 | +123.5% | 0.12% | +154.3% |
| Q2 2021 | $413,000 | +138.7% | 61,289 | +134.4% | 0.05% | +58.6% |
| Q1 2021 | $173,000 | -13.5% | 26,152 | -45.1% | 0.03% | -12.1% |
| Q4 2020 | $200,000 | +207.7% | 47,625 | +324.0% | 0.03% | +266.7% |
| Q3 2019 | $65,000 | – | 11,231 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |